DrugInformer Search

Canasa

Ingredients: Mesalamine
Average User Review Score
* Based on 56 reviews from across the web.
Wikipedia

Mesalazine (INN, BAN), also known as mesalamine (USAN) or 5-aminosalicylic acid (5-ASA), is an anti-inflammatory drug used to treat inflammatory bowel disease, such as ulcerative colitis and mild-to-moderate Crohn's disease. Mesalazine is a bowel-specific aminosalicylate drug that acts locally in the gut and has its predominant actions there, thereby having few systemic side effects.

Read more on Wikipedia
Share

  Please use Workbench for in-depth research on Canasa.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Canasa

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: None

Posted By Anonymous in fdb.rxlist.com on April 15, 2015 @ 12:00 am

I have tried many other treatments for the last two years but Canasa is the only thing that has stopped not only the bleeding but also the urgency. I use right before bed and have had no side effects...

Druginformer Identified Side Effects: Joint stiffness

Posted By ouch in fdb.rxlist.com on March 9, 2015 @ 12:00 am

he suppository is difficult to get out of the stiff plastic wrapper. Would like to have an applicator instead of using finger to insert the suppository.

Druginformer Identified Side Effects: None

Posted By Lavern in fdb.rxlist.com on July 23, 2014 @ 12:00 am

I found the treatment very helpful. I now have better control when having to use the bathroom. Haven't had an accident since using Canasa.

Druginformer Identified Side Effects: None

Posted By John in fdb.rxlist.com on February 9, 2014 @ 12:00 am

In case you have a 'yuck' reaction to the insertion of this suppository you can purchase 144 protective latex tissue finger cots from Amazon for under $5. This medication has been the most effective ...

Druginformer Identified Side Effects: Back pain

Posted By Betty in fdb.rxlist.com on November 1, 2013 @ 12:00 am

... I had proctitis and my Dr prescribed this to use. First day had adominal cramping but symtons of frequent trips to the bathroom subsided.Second day when I woke up had severe back pain. Called my Dr to...

Druginformer Identified Side Effects: Flatulence, Headache, Haemorrhage

Posted By socal in fdb.rxlist.com on July 23, 2013 @ 12:00 am

Taking for ulcerative colitis for about 3 weeks--seems to have reduced the bleeding a lot and reduced the bowel movement frequency quite a bit. Do have headaches and gas as side effects, but not too ...

Druginformer Identified Side Effects: None

Posted By Anonymous in fdb.rxlist.com on June 5, 2013 @ 12:00 am

Druginformer Identified Side Effects: Flatulence, Haemorrhage

Posted By Anonymous in fdb.rxlist.com on October 25, 2012 @ 12:00 am

Had mucous, bleeding, gas and too many trips to the bathroom. After colonscopy, I was diagnosed with localized inflammation of the lower colon. This drug worked great for the six weeks that my Dr. pre...

Druginformer Identified Side Effects: Condition aggravated

Posted By Anonymous in everydayhealth.com on July 16, 2012 @ 12:00 am

Kept my proctitus from flaring

Druginformer Identified Side Effects: Adverse event, Drug ineffective

Posted By gardengirl in fdb.rxlist.com on February 8, 2012 @ 12:00 am

I was diagnosed with proctitis 3-month, tried Canasa for 4 weeks, once a day, with prednisone. It worked well just the first week, then I had a bad flair up. This medicine seems to work well for most ...


* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.